UNLABELLED: To examine the association between renal function and fracture in multiethnic women, we studied postmenopausal women enrolled in the Women's Health Initiative. Postmenopausal White women with mild renal dysfunction were at increased risk of nonvertebral fracture; this association was at least partially explained by effects of renal dysfunction on chronic inflammation. Reduced renal function appeared to increase fracture risk among Black women, but there was little evidence to support this association among other racial/ethnic groups. INTRODUCTION: The purpose of this study was to determine whether renal function is associated with fracture risk within racial/ethnic groups. METHODS: A nested case-control study was conducted among 93,673 postmenopausal women; incident nonvertebral fractures were identified in 362 Black, 183 Hispanic, 110 Asian, and 45 American-Indian women. A random sample of 395 White women with incident nonvertebral fracture was chosen. One nonfracture control for each case was selected (matched on age, race/ethnicity, and blood draw date). Cystatin C levels were measured using baseline serum, and estimated glomerular filtration rate calculated (eGFR(cys-c)). RESULTS: Each 1 SD increase in cystatin C was associated with a 1.2-fold increased risk of fracture among White women (adjusted odds ratios [OR], 1.23; 95% confidence intervals [CI], 1.04-1.46). The OR of fracture was 1.16 (95% CI, 0.85-1.58) among women with eGFR(cys-c) 60-90 mL/min/1.73 m(2) and 2.46 (95% CI, 1.16-5.21) among those with eGFR(cys-c) <60 mL/min/1.73 m(2) compared to the reference group (eGFR(cys-c) >90 mL/min/1.73 m(2)) (p trend = 0.05). The association was reduced after adjustment for cytokine TNFα soluble receptors (OR, 1.62; 95% CI, 0.59-4.46 for eGFR(cys-c) <60 mL/min/1.73 m(2)). Among Blacks, there was an association between cystatin C and fracture risk (OR per 1 SD increase, 1.15; 95% CI, 1.00-1.32); after adjustment, this association was only modestly attenuated, but no longer statistically significant. There was no evidence of significant associations among Hispanic, Asian, or American-Indian women. CONCLUSION: Postmenopausal White women with mild renal dysfunction are at increased risk of nonvertebral fracture. Effects of renal function on chronic inflammation may mediate this association. Reduced renal function may increase fracture risk among Black women, but there was little evidence to support this association among other racial/ethnic groups.
UNLABELLED: To examine the association between renal function and fracture in multiethnic women, we studied postmenopausal women enrolled in the Women's Health Initiative. Postmenopausal White women with mild renal dysfunction were at increased risk of nonvertebral fracture; this association was at least partially explained by effects of renal dysfunction on chronic inflammation. Reduced renal function appeared to increase fracture risk among Black women, but there was little evidence to support this association among other racial/ethnic groups. INTRODUCTION: The purpose of this study was to determine whether renal function is associated with fracture risk within racial/ethnic groups. METHODS: A nested case-control study was conducted among 93,673 postmenopausal women; incident nonvertebral fractures were identified in 362 Black, 183 Hispanic, 110 Asian, and 45 American-Indian women. A random sample of 395 White women with incident nonvertebral fracture was chosen. One nonfracture control for each case was selected (matched on age, race/ethnicity, and blood draw date). Cystatin C levels were measured using baseline serum, and estimated glomerular filtration rate calculated (eGFR(cys-c)). RESULTS: Each 1 SD increase in cystatin C was associated with a 1.2-fold increased risk of fracture among White women (adjusted odds ratios [OR], 1.23; 95% confidence intervals [CI], 1.04-1.46). The OR of fracture was 1.16 (95% CI, 0.85-1.58) among women with eGFR(cys-c) 60-90 mL/min/1.73 m(2) and 2.46 (95% CI, 1.16-5.21) among those with eGFR(cys-c) <60 mL/min/1.73 m(2) compared to the reference group (eGFR(cys-c) >90 mL/min/1.73 m(2)) (p trend = 0.05). The association was reduced after adjustment for cytokine TNFα soluble receptors (OR, 1.62; 95% CI, 0.59-4.46 for eGFR(cys-c) <60 mL/min/1.73 m(2)). Among Blacks, there was an association between cystatin C and fracture risk (OR per 1 SD increase, 1.15; 95% CI, 1.00-1.32); after adjustment, this association was only modestly attenuated, but no longer statistically significant. There was no evidence of significant associations among Hispanic, Asian, or American-Indian women. CONCLUSION: Postmenopausal White women with mild renal dysfunction are at increased risk of nonvertebral fracture. Effects of renal function on chronic inflammation may mediate this association. Reduced renal function may increase fracture risk among Black women, but there was little evidence to support this association among other racial/ethnic groups.
Authors: William McClellan; David G Warnock; Leslie McClure; Ruth C Campbell; Britt B Newsome; Virginia Howard; Mary Cushman; George Howard Journal: J Am Soc Nephrol Date: 2006-04-26 Impact factor: 10.121
Authors: Kristine E Ensrud; Li-Ying Lui; Brent C Taylor; Areef Ishani; Michael G Shlipak; Katie L Stone; Jane A Cauley; Sophie A Jamal; Diana M Antoniucci; Steven R Cummings Journal: Arch Intern Med Date: 2007-01-22
Authors: Denise G von Mühlen; Gail A Greendale; Cedric F Garland; Lori Wan; Elizabeth Barrett-Connor Journal: Osteoporos Int Date: 2005-06-01 Impact factor: 4.507
Authors: Michelle C Odden; Glenn M Chertow; Linda F Fried; Anne B Newman; Stephanie Connelly; Sara Angleman; Tamara B Harris; Eleanor M Simonsick; Michael G Shlipak Journal: Am J Epidemiol Date: 2006-10-11 Impact factor: 4.897
Authors: R Ramsey-Goldman; J E Dunn; D D Dunlop; F P Stuart; M M Abecassis; D B Kaufman; C B Langman; M H Salinger; S M Sprague Journal: J Bone Miner Res Date: 1999-03 Impact factor: 6.741
Authors: Linda F Fried; Mary Louise Biggs; Michael G Shlipak; Stephen Seliger; Bryan Kestenbaum; Catherine Stehman-Breen; Mark Sarnak; David Siscovick; Tamara Harris; Jane Cauley; Anne B Newman; John Robbins Journal: J Am Soc Nephrol Date: 2006-12-13 Impact factor: 10.121
Authors: Jane A Cauley; Lieling Wu; Nina S Wampler; Janice M Barnhart; Matthew Allison; Zhao Chen; Rebecca Jackson; John Robbins Journal: J Bone Miner Res Date: 2007-11 Impact factor: 6.741
Authors: Jane A Cauley; Michelle E Danielson; Robert M Boudreau; Kimberly Yz Forrest; Joseph M Zmuda; Marco Pahor; Frances A Tylavsky; Steven R Cummings; Tamara B Harris; Anne B Newman Journal: J Bone Miner Res Date: 2007-07 Impact factor: 6.741
Authors: Kyla L Naylor; Guangyong Zou; William D Leslie; Anthony B Hodsman; Ngan N Lam; Eric McArthur; Lisa-Ann Fraser; Gregory A Knoll; Jonathan D Adachi; S Joseph Kim; Amit X Garg Journal: World J Transplant Date: 2016-06-24
Authors: Tamara Isakova; Timothy E Craven; Julia J Scialla; Thomas L Nickolas; Adrian Schnall; Joshua Barzilay; Ann V Schwartz Journal: Bone Date: 2015-04-30 Impact factor: 4.398
Authors: Michelle R Denburg; Juhi Kumar; Thomas Jemielita; Ellen R Brooks; Amy Skversky; Anthony A Portale; Isidro B Salusky; Bradley A Warady; Susan L Furth; Mary B Leonard Journal: J Am Soc Nephrol Date: 2015-07-02 Impact factor: 10.121
Authors: Kristine E Ensrud; Neeta Parimi; Howard A Fink; Areef Ishani; Brent C Taylor; Michael Steffes; Jane A Cauley; Cora E Lewis; Eric S Orwoll Journal: Am J Kidney Dis Date: 2013-07-24 Impact factor: 8.860
Authors: Kamil E Barbour; Li-Yung Lui; Kristine E Ensrud; Teresa A Hillier; Erin S LeBlanc; Steven W Ing; Marc C Hochberg; Jane A Cauley Journal: J Bone Miner Res Date: 2014-09 Impact factor: 6.741
Authors: Kristine E Ensrud; Neeta Parimi; Jane A Cauley; Areef Ishani; Yelena Slinin; Teresa A Hillier; Brent C Taylor; Michael Steffes; Steven R Cummings Journal: J Bone Miner Res Date: 2013-06 Impact factor: 6.741